Protein Expression Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By System Type ; By Application ; By End User ; By Region

Description

Global Protein Expression Market Size More Than Doubles to Reach USD 7.2 Billion by 2029.

The global protein expression market is gaining traction because of the increasing investments in R&D protein expression by biopharmaceutical companies and growing adoption of recombinant-based protein expression.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global protein expression market size at USD 3.12 billion in 2022. During the forecast period between 2023 and 2029, the global protein expression market size is projected to grow at an impressive CAGR of 12.63% reaching a value of USD 7.16 billion by 2029. The growing use of protein expression in the biopharmaceutical and life sciences sector for the development of novel medications and treatments is one of the major growth reasons for the global protein expression market. Protein expression is the subject of intensive research and development efforts as a result of the rising incidence of cancer and other chronic diseases throughout the world, which is fueling the market's expansion.

Global Protein Expression Market - Overview:

The process through which proteins are created, altered, and controlled in living organisms is referred to as protein expression. The analysis of protein expression in cancer cells may provide details about a particular type of cancer, the optimal course of treatment, and the effectiveness of a particular course of treatment. For further studies, such as identifying the three-dimensional structure of proteins, as chemical instruments or probes, or as novel classes of pharmaceuticals, among others, expressed protein products that are functional and exhibit traits comparable to their native counterparts are helpful.

Global Protein Expression Market - By End User:

Based on end users, the global protein expression market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract development and manufacturing organizations (CROs and CDMOs), academic research institutes, and others. The pharmaceutical and biotechnology company segment accounts for the highest market share. Protein expression is widely used in pharmaceutical and biotechnology companies to carry out research and develop new drugs. CROs are also gaining traction owing to increasing outsourcing of research activities at lower costs which helps companies increase their profit margins.

Impact of COVID-19 on Global Protein Expression Market

The unprecedented COVID-19 pandemic outbreak brought various growth opportunities for the global protein expression market. According to earlier research, the novel coronavirus infects people via infecting epithelial cells by connecting with the human ACE2 receptor protein on their surface. As a result, extensive research activities surrounding the study of the protein expression status of angiotensin-converting enzyme 2 (ACE2) to understand the hypothesized correlation of the level of ACE2 expression in lungs with an increased risk of severe infection and complications in COrona VIrus Disease 2019 (COVID-19). Several other types of research like these with the application of protein expression also played a crucial role in tackling the COVID-19 pandemic.

Competitive Landscape:

Major players operating in the global Protein Expression market include: Thermo Fisher Scientific, Inc., Merck KGaA, GenScript Biotech Corporation, Agilent Technologies, Inc., Takara Bio, Inc., Bio-Rad Laboratories, Inc, Qiagen N.V, Charles River Laboratories, Inc., Danaher Corporation, Sartorius AG, Corning Incorporated, FUJIFILM Irvine Scientific, Inc., Lonza Group AG, Bioneer Corporation, Promega Corporation, and Oxford Expression Technologies Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Protein Expression Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Protein Expression Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Protein Expression Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC23135

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Protein Expression Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Increasing demand for protein biologics
  - 3.2.1.2. Increasing R&D in pharmaceutical and biopharmaceutical industries
  - 3.2.1.3. Growing adoption of recombinant-based protein expression
  - 3.2.1.4. Availability of funding for protein-based research
- 3.2.2. Restraints
  - 3.2.2.1. High cost of protein expression reagents and instruments
  - 3.2.2.2. Increasing consolidation and high barriers for new entrants
- 3.2.3. Opportunities
  - 3.2.3.1. Emergence of microfluidics
  - 3.2.3.2. Emerging economies offering significant growth potential
- 3.2.4. Challenges
  - 3.2.4.1. Undesired post-translational modifications and purification
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Protein Expression Market Overview

4.1. Market Size & Forecast by Value, 2019-2029
- 4.1.1. By Value (USD Billion)
4.2. Market Share & Forecast
- 4.2.1. By System Type
  - 4.2.1.1. Mammalian Cell Expression Systems
  - 4.2.1.2. Prokaryotic expression systems
  - 4.2.1.3. Insect cell expression systems
  - 4.2.1.4. Yeast expression systems
  - 4.2.1.5. Cell-free expression systems
  - 4.2.1.6. Algal-based expression systems
- 4.2.2. By Application
  - 4.2.2.1. Therapeutic
  - 4.2.2.2. Research
  - 4.2.2.3. Industrial
- 4.2.3. By End User
  - 4.2.3.1. Pharmaceutical and Biotechnology companies
  - 4.2.3.2. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)
  - 4.2.3.3. Academic Research Institutes
  - 4.2.3.4. Others
- 4.2.4. By Region
  - 4.2.4.1. North America
  - 4.2.4.2. Europe
  - 4.2.4.3. Asia Pacific (APAC)
  - 4.2.4.4. Latin America (LATAM)
  - 4.2.4.5. Middle East and Africa (MEA)

5. North America Protein Expression Market

5.1. Market Size & Forecast by Value, 2019-2029
- 5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
- 5.2.1. By System Type
- 5.2.2. By Application
- 5.2.3. By End User
- 5.2.4. By Country
  - 5.2.4.1. US
  - 5.2.4.1.1. By System Type
  - 5.2.4.1.2. By Application
  - 5.2.4.1.3. By End User
  - 5.2.4.2. Canada
  - 5.2.4.2.1. By System Type
  - 5.2.4.2.2. By Application
  - 5.2.4.2.3. By End User

6. Europe Protein Expression Market

6.1. Market Size & Forecast by Value, 2019-2029
- 6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
- 6.2.1. By System Type
- 6.2.2. By Application
- 6.2.3. By End User
- 6.2.4. By Country
  - 6.2.4.1. Germany
  - 6.2.4.1.1. By System Type
  - 6.2.4.1.2. By Application
  - 6.2.4.1.3. By End User
  - 6.2.4.2. UK
  - 6.2.4.2.1. By System Type
  - 6.2.4.2.2. By Application
  - 6.2.4.2.3. By End User
  - 6.2.4.3. Italy
  - 6.2.4.3.1. By System Type
  - 6.2.4.3.2. By Application
  - 6.2.4.3.3. By End User
  - 6.2.4.4. France
  - 6.2.4.4.1. By System Type
  - 6.2.4.4.2. By Application
  - 6.2.4.4.3. By End User
  - 6.2.4.5. Spain
  - 6.2.4.5.1. By System Type
  - 6.2.4.5.2. By Application
  - 6.2.4.5.3. By End User
  - 6.2.4.6. The Netherlands
  - 6.2.4.6.1. By System Type
  - 6.2.4.6.2. By Application
  - 6.2.4.6.3. By End User
  - 6.2.4.7. Rest of Europe
  - 6.2.4.7.1. By System Type
  - 6.2.4.7.2. By Application
  - 6.2.4.7.3. By End User

7. Asia Pacific Protein Expression Market

7.1. Market Size & Forecast by Value, 2019-2029
- 7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
- 7.2.1. By System Type
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
  - 7.2.4.1. China
  - 7.2.4.1.1. By System Type
  - 7.2.4.1.2. By Application
  - 7.2.4.1.3. By End User
  - 7.2.4.2. India
  - 7.2.4.2.1. By System Type
  - 7.2.4.2.2. By Application
  - 7.2.4.2.3. By End User
  - 7.2.4.3. Japan
  - 7.2.4.3.1. By System Type
  - 7.2.4.3.2. By Application
  - 7.2.4.3.3. By End User
  - 7.2.4.4. South Korea
  - 7.2.4.4.1. By System Type
  - 7.2.4.4.2. By Application
  - 7.2.4.4.3. By End User
  - 7.2.4.5. Australia & New Zealand
  - 7.2.4.5.1. By System Type
  - 7.2.4.5.2. By Application
  - 7.2.4.5.3. By End User
  - 7.2.4.6. Indonesia
  - 7.2.4.6.1. By System Type
  - 7.2.4.6.2. By Application
  - 7.2.4.6.3. By End User
  - 7.2.4.7. Malaysia
  - 7.2.4.7.1. By System Type
  - 7.2.4.7.2. By Application
  - 7.2.4.7.3. By End User
  - 7.2.4.8. Singapore
  - 7.2.4.8.1. By System Type
  - 7.2.4.8.2. By Application
  - 7.2.4.8.3. By End User
  - 7.2.4.9. Philippines
  - 7.2.4.9.1. By System Type
  - 7.2.4.9.2. By Application
  - 7.2.4.9.3. By End User
  - 7.2.4.10. Vietnam
  - 7.2.4.10.1. By System Type
  - 7.2.4.10.2. By Application
  - 7.2.4.10.3. By End User
  - 7.2.4.11. Rest of APAC
  - 7.2.4.11.1. By System Type
  - 7.2.4.11.2. By Application
  - 7.2.4.11.3. By End User

8. Latin America Protein Expression Market

8.1. Market Size & Forecast by Value, 2019-2029
- 8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
- 8.2.1. By System Type
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
  - 8.2.4.1. Brazil
  - 8.2.4.1.1. By System Type
  - 8.2.4.1.2. By Application
  - 8.2.4.1.3. By End User
  - 8.2.4.2. Mexico
  - 8.2.4.2.1. By System Type
  - 8.2.4.2.2. By Application
  - 8.2.4.2.3. By End User
  - 8.2.4.3. Argentina
  - 8.2.4.3.1. By System Type
  - 8.2.4.3.2. By Application
  - 8.2.4.3.3. By End User
  - 8.2.4.4. Peru
  - 8.2.4.4.1. By System Type
  - 8.2.4.4.2. By Application
  - 8.2.4.4.3. By End User
  - 8.2.4.5. Colombia
  - 8.2.4.5.1. By System Type
  - 8.2.4.5.2. By Application
  - 8.2.4.5.3. By End User
  - 8.2.4.6. Rest of LATAM
  - 8.2.4.6.1. By System Type
  - 8.2.4.6.2. By Application
  - 8.2.4.6.3. By End User

9. Middle East & Africa Protein Expression Market

9.1. Market Size & Forecast by Value, 2019-2029
- 9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
- 9.2.1. By System Type
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
  - 9.2.4.1. Saudi Arabia
  - 9.2.4.1.1. By System Type
  - 9.2.4.1.2. By Application
  - 9.2.4.1.3. By End User
  - 9.2.4.2. UAE
  - 9.2.4.2.1. By System Type
  - 9.2.4.2.2. By Application
  - 9.2.4.2.3. By End User
  - 9.2.4.3. Qatar
  - 9.2.4.3.1. By System Type
  - 9.2.4.3.2. By Application
  - 9.2.4.3.3. By End User
  - 9.2.4.4. Kuwait
  - 9.2.4.4.1. By System Type
  - 9.2.4.4.2. By Application
  - 9.2.4.4.3. By End User
  - 9.2.4.5. South Africa
  - 9.2.4.5.1. By System Type
  - 9.2.4.5.2. By Application
  - 9.2.4.5.3. By End User
  - 9.2.4.6. Nigeria
  - 9.2.4.6.1. By System Type
  - 9.2.4.6.2. By Application
  - 9.2.4.6.3. By End User
  - 9.2.4.7. Algeria
  - 9.2.4.7.1. By System Type
  - 9.2.4.7.2. By Application
  - 9.2.4.7.3. By End User
  - 9.2.4.8. Rest of MEA
  - 9.2.4.8.1. By System Type
  - 9.2.4.8.2. By Application
  - 9.2.4.8.3. By End User

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Protein Expression Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Protein Expression Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

12.1. Thermo Fisher Scientific, Inc.
12.2. Merck KGaA
12.3. GenScript Biotech Corporation
12.4. Agilent Technologies, Inc.
12.5. Takara Bio, Inc.
12.6. Bio-Rad Laboratories, Inc
12.7. Qiagen N.V
12.8. Charles River Laboratories, Inc.
12.9. Danaher Corporation
12.10. Sartorius AG
12.11. Corning Incorporated
12.12. FUJIFILM Irvine Scientific, Inc.
12.13. Lonza Group AG
12.14. Bioneer Corporation
12.15. Promega Corporation
12.16. Oxford Expression Technologies Ltd
12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumption & Limitation